Rhumbline Advisers »

Stoke Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $216k 41k 5.26
2023-09-30 $162k 41k 3.94
2023-06-30 $448k 42k 10.63
2023-03-31 $288k 35k 8.32
2022-12-31 $316k 34k 9.24
2022-09-30 $433k 34k 12.84
2022-06-30 $421k 32k 13.22
2022-03-31 $407k 19k 21.04
2021-12-31 $431k 18k 23.97
2021-09-30 $466k 18k 25.44
2021-06-30 $588k 18k 33.66
2021-03-31 $602k 16k 38.82
2020-12-31 $971k 16k 61.96
2020-09-30 $494k 15k 33.46
2020-06-30 $402k 17k 23.82
2020-03-31 $463k 20k 22.90
2019-12-31 $225k 7.9k 28.34